<DOC>
	<DOCNO>NCT02566681</DOCNO>
	<brief_summary>The purpose study evaluate safety use autologous bone marrow stem cell seed porous tricalcium phosphate matrix demineralize bone matrix patient osteonecrosis jaw prospective , single-center , open , nonrandomized unblinded clinical trial .</brief_summary>
	<brief_title>Clinical Trial Use Autologous Bone Marrow Stem Cells Seeded Porous Tricalcium Phosphate Matrix Demineralized Bone Matrix Patients With Osteonecrosis</brief_title>
	<detailed_description />
	<mesh_term>Osteonecrosis</mesh_term>
	<criteria>Diagnosis mandibular osteonecrosis etiology define clinical radiological examination . Bone defect anteroposterior dimension less equal 4 cm mandible maxilla 2.5 , / bone bed sufficient ensure integrity construct surgery . No response conservative treatment . Provide sufficient assurance adherence protocol . Provide write consent Meet inclusion criterion Concomitant psychiatric illness . Uncontrolled concomitant systemic disease . Active infectious disease focus mandibular osteonecrosis . Neoplastic disease complete remission le 2 year . Pregnant patient . Patients active feeding . Patients physically fertile , defined woman physiologically capable become pregnant , UNLESS use reliable method contraception . Patients cardiac disease , renal , hepatic , systemic , immune may influence patient survival test . Inclusion clinical trial active treatment . Inability understand inform consent . You need meet exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>